Roche Holding Ltd. (VTX:ROG) has been assigned a consensus rating of “Hold” from the nineteen ratings firms that are covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and eight have given a buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is CHF 259.72.
Several brokerages have recently issued reports on ROG. Deutsche Bank set a CHF 255 price target on shares of Roche and gave the stock a “neutral” rating in a research note on Monday, September 11th. Berenberg Bank set a CHF 260 price target on shares of Roche and gave the stock a “neutral” rating in a research note on Tuesday, October 24th. J P Morgan Chase & Co restated a “buy” rating on shares of Roche in a research note on Monday, October 9th. Morgan Stanley set a CHF 260 price target on shares of Roche and gave the stock a “neutral” rating in a research note on Friday, October 6th. Finally, Jefferies Group set a CHF 295 price target on shares of Roche and gave the stock a “buy” rating in a research note on Monday, October 16th.
Shares of Roche (ROG) opened at CHF 242.30 on Friday. Roche has a one year low of CHF 219.10 and a one year high of CHF 273.
TRADEMARK VIOLATION NOTICE: “Roche Holding Ltd. (ROG) Receives Consensus Rating of “Hold” from Brokerages” was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece on another site, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece can be viewed at https://ledgergazette.com/2017/12/17/roche-holding-ltd-rog-receives-consensus-rating-of-hold-from-brokerages.html.
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.